¼¿ï´ëÇб³º´¿ø (¿Â¶óÀÎ) 2022³â ½Å°æ°ú ¿¬¼ö°Á (SNUH Neurology Update 2022) : 2022-10-29±³À°ÀÏÀÚ : 2022-10-29
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) 2022³â ½Å°æ°ú ¿¬¼ö°Á (SNUH Neurology Update 2022)ÁÖÃÖ±â°ü : ¼¿ï´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½Å°æ°ú
´ã´çÀÚ : ÀÓÀº¿µ
¿¬¶ôó : 02-2072-2237
À̸ÞÀÏ :
imyou@snu.ac.kr ±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 17 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í Àü°øÀÇ ¹× °£È£»ç µî 40,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 06:00~06:30 Bacterial Infectious Diseases in CNS: update ÁÖ °Ç(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 06:30~07:00 Autoimmune Encephalitis: update À̼øÅÂ(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 07:00~07:30 Neurogenetics: Updates ¹®Àå¼·(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 07:30~08:00 Vascular vertigo: Update on diagnostic criteria ±èÁö¼ö(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 08:00~08:30 Central vestibular system: its role in clinical manifestations other than eye movements ÃÖÁ¤À±(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 08:30~09:00 New AEDs so farr ÀÌ»ó°Ç(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 09:00~09:30 drug interaction in epilepsy patient ¹Ú°æÀÏ(°³²¼¾ÅÍ)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 09:30~10:00 management of central sleep apnea Á¤±â¿µ(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 10:00~10:30 update in epilepsy syndrome ±¸´ë¸²(º¸¶ó¸Åº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 10:30~11:00 Seizures and EEG patterns in critically ill patients ÀÌ¿ìÁø(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 11:00~11:30 metabolic encephalopathy - evaluation and examination °ÁöÈÆ(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 11:30~12:00 functional movement disorder ¹ÚÇý¿µ(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 12:00~12:30 Avoiding adverse drug events in hospitals : Clinical practice in Neurology ¾È¼±Àç(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 12:30~13:00 subacute and chronic menigitis ÀÌÇÑ»ó(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 13:00~13:30 Nutritional & Respiratory Support for Patients with Neuromuscular Disorders ÃÖ¼®Áø(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 13:30~14:00 ÀÌ»ó¿îµ¿Áúȯ¿¡¼ Áø´Ü¿¡ µµ¿òÀÌ µÇ´Â ³ú¿µ»ó ¼Ò°ß ±èÇÑÁØ(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 14:00~14:30 ÆÄŲ½¼º´ÀÇ ÁøÇàÀ» ¸ØÃß°í ÁÁ°Ô ÇÒ ¼ö ÀÖ´Â ¹Ì·¡ÀÇ Ä¡·á ±èÁ¾¹Î(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 14:30~15:00 Diagnosis and Management of chorea(dyskinesia) and other hyperkinetic movement disorders - 2) drug-induced ÀÌÁö¿µ(º¸¶ó¸Åº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 15:00~15:30 Lipid Metabolism and guideline À̽ÂÈÆ(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 15:30~16:00 Post cardiac arrest syndrome care °í»ó¹è(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 16:00~16:30 Intracranial artery stenosis: stenting effective? Á¤±ÙÈ(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 16:30~17:00 Arterial stiffness and cerebral small vessel disease ±èÁ¤¹Î(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 17:00~17:30 The future of endovascdular treatment: Going beyond DAWN and DEFUSE-3 trials ÀÌÀÀÁØ(¼»êÀÇ·á¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 17:30~18:00 Perioperative stroke risk and preoperative optimization for cerebrovascular problem Á¤ÇÑ¿µ(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 18:00~18:30 Practical tips for target temperature management in ICU ±èÅÂÁ¤(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 18:30~19:00 Mechanism of ICH: beyond hypertension ±è¹üÁØ(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 19:00~19:30 Post-EVT care: Hemorrhagic complications ±èÁØ¿±(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 19:30~20:00 Surrogate markers of cerebral small vessel disease in the healthy population ±ÇÇü¹Î(º¸¶ó¸Åº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 20:00~20:30 Cancer, a dangerous companion of stroke ³²±â¿õ(º¸¶ó¸Åº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 20:30~21:00 How to evaluate cognitive function ¹Ú¿µÈ£(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 21:00~21:30 A new horizon in migraine therapy - ditan, gepants, and anti-CGRP(R) monoclonal antibodies À̹ÌÁö(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 21:30~22:00 Biomarkers in Multiple Sclerosis ±èÁؼø(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 22:00~22:30 Diagnostic Challenge in ALS ¼ºÁ¤ÁØ(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 22:30~23:00 A Practical Approach to Pain in Neurology ¹Ú°æ¼®(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-29 ¿Â¶óÀÎ 23:00~23:30 Common pitfalls in EMG lab È«À±È£(º¸¶ó¸Åº´¿ø)